Oxford-Harrington Rare Disease Centre Bio Tech Profile Feature in PharmaSource
“We embed industry expertise directly into academia through our Scholar Award program, which provides a miniâbiotech/pharma team to each OxfordâHarrington Scholar we support,” says Matthew Anderson, CoâDirector of the OxfordâHarrington Rare Disease Centre. Each Scholar receives drug development, commercial strategy, and business development support—an approach designed... Continue Reading
April 16, 2026
Breaking Into the Brain: Overcoming Barriers to Understand Autism and Brain Tumors
In a new episode of the podcast, , welcomes , and , for a conversation on how immune biology is transforming the field of neuroscience and accelerating the path from discovery to patient care.Dr. Anderson, Investigator at Harrington Discovery Institute and Co-Director of the —a partnership between the University of Oxford and the Harrington Discovery Institute at University Hospitals—brings... Continue Reading
